Lazabemide
Lazabemide is a reversible and selective monoamine [oxidase inhibitor|inhibitor] of monoamine oxidase B that was under development as an Management of [Parkinson's disease#Medication|antiparkinsonian] agent but was never marketed.
Lazabemide is a reversible and selective monoamine [oxidase inhibitor|inhibitor] of monoamine oxidase B that was under development as an Management of [Parkinson's disease#Medication|antiparkinsonian] agent but was never marketed.